Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03671902 · ClinicalTrials.gov registry record · NA
Noninvasive Monitoring in Lower Body Negative and Positive Pressure Tests
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03671902 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03671902, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of these studies is to assess the use of phonocardiograhy to monitor blood volume. We will evaluate phonocardiographic parameters in normal subjects in increasing levels of lower body negative pressure (LBNP) and lower body positive pressure (LBPP).
Interventions
- DEVICE Fluid shift
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03671902
The ClinicalTrials.gov registry entry for NCT03671902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluid shift is the first listed.
NCT03671902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03671902 about?
NCT03671902 is a clinical study titled "Noninvasive Monitoring in Lower Body Negative and Positive Pressure Tests". The goal of these studies is to assess the use of phonocardiograhy to monitor blood volume. We will evaluate phonocardiographic parameters in normal subjects in increasing levels of lower body negative pressure (LBNP) and lower body positive pressure (LBPP).
What is the current status of trial NCT03671902?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-02-01. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT03671902?
The interventions under investigation include: Fluid shift (DEVICE).
Who is sponsoring clinical trial NCT03671902?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.